Imipenem Resistance in Aerobic Gram-Negative Bacteria
- 1 January 1998
- journal article
- Published by Maney Publishing in Journal of Chemotherapy
- Vol. 10 (2) , 97-101
- https://doi.org/10.1179/joc.1998.10.2.97
Abstract
A prospective study was undertaken to observe the emergence of resistance to imipenem, if any, among aerobic gram-negative bacteria. A total of 736 isolates were tested during 1994-95 and less than 1% of them were resistant to imipenem, whereas the next year ('95-'96) the rate increased to 11 of the 903 isolates tested. The resistant isolates during '94-'95 were all Stenotrophomonas maltophilia whereas the spectrum of resistant bacterial species increased in '95-'96 to include Pseudomonas aeruginosa, Burkholderia cepacia, Acinetobacter calcoaceticus, Enterobacter cloacae, Proteus mirabilis and Morganella morganii with a tendency to an increase in the minimum inhibitory concentration (MIC) in the later part of the year. A majority (72%) of the resistant isolates were from patients with burns, and burn wounds were most frequently infected with such organisms. These data suggest that over a period of time aerobic gram-negative bacteria may develop resistance to imipenem and the pool of such bacteria increases with extensive use of the drug. Non-fermentative aerobic bacteria tend to develop resistance faster with widespread dissemination than Enterobacteriaceae. Hospital Burn Units are a potential source of development of such resistance.Keywords
This publication has 9 references indexed in Scilit:
- Antibiotic Resistance: Proceedings of a Symposium Held on 12 July 1996 at the University of SouthamptonJournal of Medical Microbiology, 1997
- Transferable imipenem-resistance in Acinetobacter species from a clinical sourceJournal of Antimicrobial Chemotherapy, 1995
- CarbapenemsMedical Clinics of North America, 1995
- Mechanisms of resistance to the carbapenemsJournal of Antimicrobial Chemotherapy, 1995
- Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein.Proceedings of the National Academy of Sciences, 1994
- Transferable imipenem resistance in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1991
- Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1990
- Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa InfectionsThe Journal of Infectious Diseases, 1986
- Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosisJournal of Antimicrobial Chemotherapy, 1985